Leadership Overview
Vanda Pharmaceuticals has 5 executives leading key functions including strategy, finance, and marketing.
Driven by a commitment to patient well-being, Vanda Pharmaceuticals focuses on developing innovative medicines through advanced genetics and genomics, aiming to significantly improve patient lives globally.
Driven by a commitment to patient well-being, Vanda Pharmaceuticals focuses on developing innovative medicines through advanced genetics and genomics, aiming to significantly improve patient lives globally.
Leadership Roles at Vanda Pharmaceuticals
Behrouz Ahmadinejad - Chief Executive Officer
Behrouz Ahmadinejad, the Chief Executive Officer at Vanda Pharmaceuticals, directs the company's overarching strategic vision and operational execution. Ahmadinejad guides the organization's commitment to developing innovative medicines, leveraging advanced technologies like genetics and genomics to accelerate drug discovery and clinical trial processes. This leadership role ensures the company's commercial strategies align with its mission to improve patient lives. The Chief Executive Officer oversees the integration of research findings into tangible pharmaceutical products and delivery methods. Behrouz Ahmadinejad's focus remains on advancing medical research and drug development across various health conditions, maintaining Vanda Pharmaceuticals' global presence in North America, Europe, and Asia.
Mihael Polymeropoulos - President, Chief Executive Officer & Chairman
Mihael Polymeropoulos, the President, Chief Executive Officer & Chairman at Vanda Pharmaceuticals, sets the strategic direction and governance framework for the biopharmaceutical company. Polymeropoulos champions the development of innovative medicines, utilizing cutting-edge genetics and genomics to drive discovery and clinical trials. This executive leadership ensures the company's commercial strategies effectively translate advanced research into improved patient outcomes. The President, Chief Executive Officer & Chairman oversees the entire product lifecycle, from initial research to novel therapeutic approaches and delivery methods. Mihael Polymeropoulos's role is critical in maintaining Vanda Pharmaceuticals' global operations across North America, Europe, and Asia, advancing medical research and drug development for diverse health conditions.
Paul Jones - Chief Financial Officer
Paul Jones, the Chief Financial Officer at Vanda Pharmaceuticals, manages the company's financial operations and fiscal strategy. Jones oversees all aspects of financial planning, budgeting, and reporting, ensuring robust resource allocation for research and development initiatives. This critical role supports the company's mission to create innovative medicines by securing and managing the necessary capital for advanced technologies, including genetics and genomics. The Chief Financial Officer ensures financial compliance and drives economic efficiency across Vanda Pharmaceuticals' global operations in North America, Europe, and Asia. Paul Jones's financial oversight is integral to advancing medical research and drug development for various health conditions, supporting the commercialization of novel therapeutic approaches.
Kim Wijkstrom - Senior Vice President. Chief Marketing Officer. Executive Leadership Team
Kim Wijkstrom, the Senior Vice President. Chief Marketing Officer. Executive Leadership Team at Vanda Pharmaceuticals, spearheads the company's market strategy and product commercialization. Wijkstrom directs the go-to-market plans for innovative medicines, translating complex scientific advancements in genetics and genomics into accessible patient solutions. This leadership position ensures Vanda Pharmaceuticals' commercial strategies effectively reach target patient populations and healthcare providers across North America, Europe, and Asia. The Senior Vice President. Chief Marketing Officer. Executive Leadership Team oversees brand development and market penetration for novel therapeutic approaches and delivery methods. Kim Wijkstrom's expertise is vital in driving the company's growth and impact in advancing medical research and drug development for various health conditions.
Joakim Wijkstrom - Senior Vice President, Chief Marketing Officer
Joakim Wijkstrom, the Senior Vice President, Chief Marketing Officer at Vanda Pharmaceuticals, drives the strategic marketing initiatives for the company's pharmaceutical products. Wijkstrom leads the development and execution of comprehensive marketing plans, focusing on communicating the value of innovative medicines derived from advanced genetics and genomics research. This role ensures effective market penetration and patient access across Vanda Pharmaceuticals' global operations in North America, Europe, and Asia. The Senior Vice President, Chief Marketing Officer oversees all promotional activities and market analysis to support the commercialization of novel therapeutic approaches and delivery methods. Joakim Wijkstrom's leadership is essential for advancing medical research and drug development for various health conditions, reinforcing the company's commitment to improving patient lives.
Explore Leadership Teams in Manufacturing
AstraZeneca focuses on the discovery, development, and commercialization of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. AstraZeneca is based in the United Kingdom.
Company Leadership RH
KO
Unither Pharmaceuticals is a global contract development and manufacturing organization (CDMO) specializing in the production of single-dose liquid pharmaceuticals and sterile unit-dose formats for the pharmaceutical and consumer healthcare industries. The company is recognized as a world leader in blow-fill-seal technology, an advanced aseptic manufacturing process that forms, fills, and seals plastic containers in a continuous automated operation, ensuring high levels of sterility and product integrity. Unither's expertise encompasses the development and manufacturing of various liquid dosage forms including oral solutions, suspensions, nasal sprays, eye drops, and other sterile and non-sterile pharmaceutical products delivered in innovative single-dose formats. The company serves a diverse client base of pharmaceutical companies, biotechnology firms, and consumer health brands, providing comprehensive services from formulation development and clinical trial manufacturing to commercial-scale production and packaging. With manufacturing facilities strategically located across multiple continents including Europe and North America, Unither maintains strict quality standards and regulatory compliance with international pharmaceutical guidelines including FDA and EMA requirements. The company emphasizes innovation in drug delivery systems, patient convenience, and sustainability while helping clients bring their pharmaceutical products to market efficiently through its specialized manufacturing capabilities and technical expertise in unit-dose liquid formulations.
Company Leadership HH
JK
MC
MB
Founded in 1950 and headquartered in Hortolândia, Brazil, EMS Pharma is a domestic pharmaceutical company. They are a distributor of pharmaceuticals in Brazil.
Company Leadership OS
KK
RC
Crown Laboratories, founded in 2000 and based in Johnson City, TN, provides pharmaceutical and ethical OTC products to the medical marketplace and contract manufacturing to the pharmaceutical industry.
Company Leadership KW
JS
JT
EP
Frequently Asked Questions Regarding Vanda Pharmaceuticals Top Executives and Leadership Team
